ArticleNanomaterials (Basel, Switzerland)2025
Sustainable Antibacterial Chitin Nanofiber/ZnO Nanohybrid Materials: Ex Situ and In Situ Synthesis, Characterization and Evaluation.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bio-Derived Cellulose Nanofibers for the Development Under Environmentally Assessed Conditions of Cellulose/ZnO Nanohybrids with Enhanced Biocompatibility and Antimicrobial Properties.Materials (Basel, Switzerland) · 2026Article
- Engineering Mesoporous Silica Hosts for Ultrasmall ZnO Nanoparticles: A Dendritic Polymer-Assisted Strategy Towards Sustainable, Safe, and Effective Antibacterial Systems.Nanomaterials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Diseases caused by infection are a threat to human health and the world economy, with bacterial infections being responsible for a large portion of hospitalizations, morbidity, and mortality, which necessitates the quest for advanced medications and/or sustainable antibacterial strategies. This study aims to develop bioderived chitin nanofibers (ChNFs) and ZnO nanoparticles to produce non-toxic nanohybrid materials with improved aqueous stability and enhanced antibacterial properties. These nanohybrids were formed via either (i) an ex situ route by mixing the ChNFs with ZnO nanoparticles prepared by flame spray pyrolysis or (ii) an in situ route resulting in ZnO nanoparticles being formed and embedded into ChNFs by a simple aqueous hydrothermal process, utilizing a low-cost Zn inorganic precursor. The ChNFs, the ZnO nanoparticles, and the nanohybrids were physicochemically characterized for their size, morphology, charge and stability. Their antibacterial activity was evaluated against Gram (-)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.